|Bid||0.00 x 100|
|Ask||0.00 x 100|
|Day's Range||253.37 - 265.71|
|52 Week Range||216.47 - 280.10|
|Beta (3Y Monthly)||1.07|
|PE Ratio (TTM)||102.80|
|Earnings Date||Dec 6, 2018|
|Forward Dividend & Yield||0.06 (0.02%)|
|1y Target Est||283.09|
PLEASANTON, Calif., Nov. 15, 2018 -- The Cooper Companies, Inc. (NYSE: COO) will participate in the BMO Prescriptions for Success Healthcare Conference in New York, NY, on.
SAN ANTONIO, Nov. 8, 2018 /PRNewswire/ -- A distinguished panel of global authorities in myopia management gathered this week in Texas, on the eve of the American Academy of Optometry (AAOptom) Annual Meeting, seeking ways to help eye care professionals better assess and manage the growing epidemic among children. The Myopia Management Expert Forum was conceived by CooperVision, which hosted the series of lectures, guided discussions and professional networking sessions. "Much like we have seen at other major academic and clinical conferences over the past year, raising awareness of and more effectively addressing childhood myopia will be one of the most deliberated issues in San Antonio this week," said Stuart Cockerill, Senior Director, Myopia Management at CooperVision.
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support.
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed it established six new positions when it released its third-quarter portfolio. Warning! GuruFocus has detected 7 Warning Signs with COO.
The PGTaiSM technology platform is a ground-breaking platform that harnesses the power of artificial intelligence (AI) and machine learning to improve PGT-A calling, interpretation, and reporting. Built on data of 1000+ biopsies that led to healthy babies, a vastly larger dataset for baseline than other available PGT-A software in use today, the PGTaiSM technology platform provides robust data analysis, reporting and interpretation. To ensure the platform was ready for any clinical situation, sequencing data from 10,000+ embryos and 5 million data points were analysed by the PGTaiSM technology platform and reviewed for accuracy in interpretation and reporting.
Johnson & Johnson (NYSE:JNJ) has rallied nicely since the summer. JNJ stock touched a 15-month low in late May — but it’s rallied nicely. Johnson & Johnson stock touched an eight-month high last month before a modest pullback of late.
Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SINGAPORE, Sept. 26, 2018 /PRNewswire/ -- New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later. CooperVision recently presented the multi-year study's latest outcomes during the BCLA Asia 2018 conference in Singapore, at which the globally increasing prevalence of myopia was among the most widely discussed issues.
SINGAPORE, Sept. 17, 2018 /PRNewswire/ -- New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later. CooperVision is presenting the multi-year study's latest outcomes during the BCLA Asia conference in Singapore this week, at which the globally increasing prevalence of myopia is among the most widely discussed issues.
Cooper Cos. (COO) delivered earnings and revenue surprises of -2.60% and 1.00%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
PLEASANTON, Calif., Aug. 30, 2018-- The Cooper Companies, Inc. today announced financial results for the fiscal third quarter ended July 31, 2018.. Revenue increased 19% year-over-year to $660.0 million. ...
NEW YORK, NY / ACCESSWIRE / August 30, 2018 / Cooper Companies, Inc. (NYSE: COO ) will be discussing their earnings results in their Q3 Earnings Call to be held on August 30, 2018 at 5:00 PM Eastern Time. ...
Cooper (NYSE: COO ) will be releasing its next round of earnings this Thursday. For all of the relevant information, here is your guide for Thursday's Q3 earnings announcement. Earnings and Revenue Based ...